(95 days)
Not Found
No
The summary describes a standard Continuous Wave Doppler device for measuring blood flow and calculating hemodynamic parameters. There is no mention of AI or ML in the device description, intended use, or performance studies. The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found".
No
The device is described as a non-invasive tool to measure and record changes in hemodynamic status, and as a diagnostic ultrasound imaging device. It provides information for quantitative evaluation, but no mention of treatment or therapy is made.
Yes
The "Intended Use / Indications for Use" section explicitly states "Diagnostic ultrasound imaging or fluid flow analysis of the human body for Pediatric (CWD), Cardiac (CWD)" and "Its recording and storage of patient information provides trending information of cardiovascular performance for quantitative evaluation." These statements indicate the device is used for diagnostic purposes by analyzing cardiac hemodynamics and blood flow.
No
The device description explicitly states it is a "portable Continuous Wave Doppler device using an Ultrasonic Transducer to measure blood flow" and weighs less than 7 kilograms, indicating it includes significant hardware components beyond just software.
Based on the provided information, the USCOM 1A is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. The USCOM 1A directly measures physiological parameters (blood flow, stroke volume, cardiac output) within the patient's body using ultrasound.
- The intended use and device description clearly state that the USCOM 1A is a non-invasive tool that measures and records changes in the hemodynamic status of a patient. It uses an ultrasonic transducer applied to the patient's skin to target the pulmonary or aortic valves.
- There is no mention of analyzing biological specimens.
The USCOM 1A is a diagnostic ultrasound device used for non-invasive hemodynamic monitoring.
N/A
Intended Use / Indications for Use
USCOM 1A records and monitors beat-to-beat cardiac heamodynamics in paediatric and adult patients. Its recording and storage of patient information provides trending information of cardiovascular performance for quantitative evaluation. The USCOM 1A is for use by clinicians in the hospital environment.
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application: Pediatric, Cardiac
Mode of Operation: CWD (new indication)
Product codes
90 IYN, 74 DSB, ITX
Device Description
The USCOM 1A is a non-invasive tool that measures and records changes in the heamodynamic status of a patient. It is a portable Continuous Wave Doppler device using an Ultrasonic Transducer to measure blood flow. it is a portable of an easy to use touch screen display with monitoring, trending and storage The GOOM TH consisted on an odo, to a see navigates intuitive and simple screens to enter patient details and perform examinations. Targeting the patient's pulmonary or aortic valves transcutaneously, the blood flow profile can be Targeting the palifically of assisted blood flow profile, the clinician can determine a number of parameters including Stroke Volume and Cardiac Output. The USCOM 1A saves the measures in a patient file. Multiple saved measures over time are displayed The USOW TA Saves the model of the patient's change in heamodynamic status. Reports can be generated on patient measures which can be printed and exported for analysis. The device is portable, weighing less than 7 kilograms and incorporates an internal battery.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Pulmonary or aortic valves
Indicated Patient Age Range
paediatric and adult patients
Intended User / Care Setting
clinicians in the hospital environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical tests: The device has been tested for acoustic output, electrical safety including thermal properties, EMC, biocompatibility, mechanical and environmental characteristics and has been found to comply with applicable medical device safety and performance standards.
Clinical tests: None required. Testing to consensus performances standards and well proven test methods is sufficient to demonstrate that the Continuous Wave Doppler technology used in the USCOM 1A, can perform clinical requirements as intended by USCOM Ltd.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo for USCOM LTD, a company that specializes in ultrasonic cardiac output monitors. The logo features a circular graphic on the left, followed by the company name in bold, sans-serif font. Below the company name is the tagline "Ultrasonic Cardiac Output Monitors" in a smaller font size. The overall design is clean and professional, conveying a sense of expertise and reliability in the medical technology field.
Ko43139
510(k) Summary - USCOM 1A
510(k) Summary
Per 21 CFR Part 807.92
Section a):
FEB 1 5 2005
| Date Prepared | Tuesday, 9th Nov 2004 |
|---|---|
| Official Contact | Mr Nick Schicht |
| USCOM Ltd | |
| Level 7 | |
| 10 Loftus Street | |
| Sydney, Australia | |
| 2000 | |
| Classification Reference | 90 IYN |
| Product Code | 21 CFR 892.1550 |
| Common/Usual Name | Pulsed-Doppler |
| Proprietary Name | USCOM 1A |
| Predicate Device(s) | 1): (K020789) GE Vivid 3 Expert/Pro Diagnostic Ultrasound System. |
| Ultrasonic Pulsed Doppler Imaging System, 21 CFR 892.1550, | |
| 90-IYN | |
| 2): (K011439) BioZ.com HemoDynamic Monitor, 21 CFR 870.2770, | |
| DSB | |
| Reason for submission | New Device |
| Indications for Use | USCOM 1A records and monitors beat-to-beat cardiac heamodynamics |
| in paediatric and adult patients. Its recording and storage of patient | |
| information provides trending information of cardiovascular performance | |
| for quantitative evaluation. | |
| The USCOM 1A is for use by clinicians in the hospital environment. |
Device Description
The USCOM 1A is a non-invasive tool that measures and records changes in the heamodynamic status of a patient.
It is a portable Continuous Wave Doppler device using an Ultrasonic Transducer to measure blood flow. it is a portable of an easy to use touch screen display with monitoring, trending and storage The GOOM TH consisted on an odo, to a see navigates intuitive and simple screens to enter patient details and perform examinations.
Targeting the patient's pulmonary or aortic valves transcutaneously, the blood flow profile can be Targeting the palifically of assisted blood flow profile, the clinician can determine a number of parameters including Stroke Volume and Cardiac Output.
The USCOM 1A saves the measures in a patient file. Multiple saved measures over time are displayed The USOW TA Saves the model of the patient's change in heamodynamic status. Reports can be generated on patient measures which can be printed and exported for analysis.
The device is portable, weighing less than 7 kilograms and incorporates an internal battery.
1
Image /page/1/Picture/1 description: The image shows the logo for USCOM LTD, a company that specializes in ultrasonic cardiac output monitors. The logo consists of a circular emblem on the left, featuring a stylized image of sound waves emanating from a central point. To the right of the emblem, the company name "USCOM LTD" is displayed in bold, uppercase letters. Below the company name, the tagline "Ultrasonic Cardiac Output Monitors" is written in a smaller font size.
Comparison with Predicate Device(s)
The USCOM 1A system is of comparable type and is substantially equivalent to the:
- GE Vivid 3 Expert/Pro system for CW Doppler performance having similar technological ﺍﻟﺘ characteristics for safety and effectiveness features, design, construction and materials with the similar Intended Use and clinical application, and;
- BioZ.com HemoDynamic Monitor for patient data storage, and retrieval functionality. ﻟﻠﺰ
Section b):
Non-clinical tests
The device has been tested for acoustic output, electrical safety including thermal properties, EMC, biocompatibility, mechanical and environmental characteristics and has been found to comply with applicable medical device safety and performance standards.
Clinical tests
None required. Testing to consensus performances standards and well proven test methods is sufficient to demonstrate that the Continuous Wave Doppler technology used in the USCOM 1A, can perform clinical requirements as intended by USCOM Ltd.
Conclusion
The intended use and key features are consistent with traditional clinical practice, FDA guidelines and established methods of patient examination. The product development and design of the device conforms to 21 CFR 820 Quality System Regulation (QSR) and ISO 13485 Quality Management System standards for medical device manufacturers. The product is designed to conform to FDA consensus standards such as electrical safety, EMC and performance, compliance has been verified through use of independent test houses. Therefore, it is concluded that the USCOM 1A system is substantially equivalent with respect to safety and effectiveness to the predicate devices, Vivid 3 from GE Medical Systems (K020789) and BioZ from CardioDynamics (K011439)
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter of the circle. Inside the circle is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 1 5 2005
USCOM Ltd. % Ms. Christina L. Kichula Manager, Regulatory Affairs PPD Medical Device 1700 Rockville Pike, Suite 400 ROCKVILLE MD 20852
Re: K043139
Trade Name: USCOM 1A Regulation Number: 21 CFR 870.2770 Regulation Name: Impedance plethysmograph Product Code: 74 DSB Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: 90 IYN and ITX Dated: January 27, 2005 Received: January 27, 2005
Dear Ms. Kichula:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your over determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device micrslate commerce pror to that have been reclassified in accordance with the provisions of the Amendinents, of to devices and Cosmetic Act (Act). You may, therefore, market the device, subject to I cleral i ood, Drug, and Oosment 110 et. The general controls provisions of the Act include the general conners provisions of and listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the USCOM 1A, as described in your premarket notification:
Transducer Model Number
2.2MHz 10mm diameter probe 2.2MHz 15mm diameter probe
3
3.3MHz 10mm diameter probe
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it your device is exassined (sis a a) =>
it may be subject to such additional controls. Existing major regulations and control It may be subject to sach additions, Title 21, Parts 800 to 898. In addition, FDA can be found in the overouncements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Flease oe advised that I Dri of issualites vour device complies with other requirements of the Act that I DA has made a actuations administered by other Federal agencies. You must Of any I cocharates and regaranents, including, but not limited to: registration and listing (21 comply with an the 11et 31equirements)01); good manufacturing practice requirements as set CFK Part 807), labeling (21 CFR Part 820); and if applicable, the electronic forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed noutication. The I D7X Imanig of succiantial vice and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific auriles in 1988. at (240) 276-0120. Also, please note the regulation entitled, Colliact the Office of Compunance as (21 t notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general international and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
If you have any questions regarding the content of this letter, please contact REVIEWER at (301) 594-1212.
Sincerely yours,
David A. Ingram
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
4
Image /page/4/Picture/1 description: The image shows the logo for USCOM LTD, a company that specializes in ultrasonic cardiac output monitors. The logo consists of a circular graphic on the left, followed by the company name in bold, uppercase letters. Below the company name is the tagline "Ultrasonic Cardiac Output Monitors" in a smaller font.
Diagnostic Ultrasound Indications for Use Form USCOM 1A
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color | |||||
| Doppler | Amplitude | |||||||||
| Doppler | Color | |||||||||
| Velocity | ||||||||||
| Imaging | Combined | |||||||||
| (specify) | Other | |||||||||
| (specify) | ||||||||||
| Ophthalmic | ||||||||||
| Fetal | ||||||||||
| Abdominal | ||||||||||
| Intraoperative | ||||||||||
| (specify) | ||||||||||
| Intraoperative | ||||||||||
| Neurological | ||||||||||
| Pediatric | N | |||||||||
| Small Organ | ||||||||||
| (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardiac | N | |||||||||
| Transesophageal | ||||||||||
| Transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral | ||||||||||
| Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletal | ||||||||||
| Conventional | ||||||||||
| Musculo-skeletal | ||||||||||
| Superficial | ||||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(Please DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K043139
5
Image /page/5/Picture/0 description: The image shows the logo for USCOM LTD, a company that specializes in Ultrasonic Cardiac Output Monitors. The logo consists of a circular graphic on the left, followed by the company name in bold, uppercase letters. Below the company name is the tagline "Ultrasonic Cardiac Output Monitors" in a smaller font. The logo is simple and professional, and it effectively communicates the company's focus on cardiac output monitoring technology.
Diagnostic Ultrasound Indications for Use Form USCOM 1A with 2.2MHz 10mm diameter probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color | ||||||
| Doppler | Amplitude | ||||||||||
| Doppler | Color | ||||||||||
| Velocity | |||||||||||
| Imaging | Combined | ||||||||||
| (specify) | Other | ||||||||||
| (specify) | |||||||||||
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative | |||||||||||
| (specify) | |||||||||||
| Intraoperative | |||||||||||
| Neurological | |||||||||||
| Pediatric | N | ||||||||||
| Small Organ | |||||||||||
| (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardiac | N | ||||||||||
| Transesophageal | |||||||||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral | |||||||||||
| Vascular | |||||||||||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculo-skeletal | |||||||||||
| Superficial | |||||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(Please do not WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Yorick R. Lymm
(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________
6
Image /page/6/Picture/0 description: The image shows the logo for USCOM LTD, a company that specializes in Ultrasonic Cardiac Output Monitors. The logo consists of a circular emblem on the left, followed by the company name in bold, uppercase letters. Below the company name, there is a tagline that describes the company's focus on ultrasonic cardiac output monitors. The logo is simple and professional, and it effectively communicates the company's brand identity.
Diagnostic Ultrasound Indications for Use Form USCOM 1A with 2.2MHz 15mm diameter probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color | ||||||
| Doppler | Amplitude | ||||||||||
| Doppler | Color | ||||||||||
| Velocity | |||||||||||
| Imaging | Combined | ||||||||||
| (specify) | Other | ||||||||||
| (specify) | |||||||||||
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative | |||||||||||
| (specify) | |||||||||||
| Intraoperative | |||||||||||
| Neurological | |||||||||||
| Pediatric | N | ||||||||||
| Small Organ | |||||||||||
| (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardiac | N | ||||||||||
| Transesophageal | |||||||||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral | |||||||||||
| Vascular | |||||||||||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculo-skeletal | |||||||||||
| Superficial | |||||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(Please DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Lorida h. Lynn
(Division Sign Off)
(Division Sign-Off) Durision of Reproductive, Abdominal, ﺔ ﻓ Pornitogical Dence к Матрет 15
7
Image /page/7/Picture/1 description: The image shows the logo for USCOM LTD, a company that specializes in Ultrasonic Cardiac Output Monitors. The logo features a circular emblem on the left, containing a stylized representation of sound waves or a fingerprint. To the right of the emblem, the company name "USCOM LTD" is displayed in bold, uppercase letters. Below the company name, the tagline "Ultrasonic Cardiac Output Monitors" is printed in a smaller font size.
Diagnostic Ultrasound Indications for Use Form USCOM 1A with 3.3MHz 10mm diameter probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color | |||||
| Doppler | Amplitude | |||||||||
| Doppler | Color | |||||||||
| Velocity | ||||||||||
| Imaging | Combined | |||||||||
| (specify) | Other | |||||||||
| (specify) | ||||||||||
| Ophthalmic | ||||||||||
| Fetal | ||||||||||
| Abdominal | ||||||||||
| Intraoperative | ||||||||||
| (specify) | ||||||||||
| Intraoperative | ||||||||||
| Neurological | ||||||||||
| Pediatric | N | |||||||||
| Small Organ | ||||||||||
| (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardiac | N | |||||||||
| Transesophageal | ||||||||||
| Transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral | ||||||||||
| Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletal | ||||||||||
| Conventional | ||||||||||
| Musculo-skeletal | ||||||||||
| Superficial | ||||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation-(ODE)
David A. Hyon
(Division Sign-Off)
Division of Reproductive, Abdominal മാർ വാർശിന്ത്രിയിരുന്നു. in 145 vumper ________________________________________________________________________________________________________________________________________________________________